Mitoxantrone Impurity 1, with the CAS number 1160572-37-1, is a chemical compound associated with the pharmaceutical agent mitoxantrone, which is primarily used in cancer treatment and for certain autoimmune diseases. As an impurity, it may arise during the synthesis or degradation of mitoxantrone. The characteristics of this compound typically include its molecular structure, which may exhibit specific functional groups that influence its chemical reactivity and stability. Impurities like this can affect the efficacy and safety profile of the primary drug, making their characterization important for quality control in pharmaceutical manufacturing. The compound may be analyzed using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry to determine its concentration and potential effects. Understanding the properties of such impurities is crucial for regulatory compliance and ensuring the therapeutic effectiveness of the primary drug while minimizing adverse effects.

Mitoxantrone Impurity 1

1160572-37-1: Mitoxantrone Impurity 1, with the CAS number 1160572-37-1, is a chemical compound associated with the pharmaceutical agent mitoxantrone, which is primarily used in cancer treatment and for certain autoimmune diseases. As an impurity, it may arise during the synthesis or degradation of mitoxantrone. The characteristics of this compound typically include its molecular structure, which may exhibit specific functional groups that influence its chemical reactivity and stability. Impurities like this can affect the efficacy and safety profile of the primary drug, making their characterization important for quality control in pharmaceutical manufacturing. The compound may be analyzed using techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry to determine its concentration and potential effects. Understanding the properties of such impurities is crucial for regulatory compliance and ensuring the therapeutic effectiveness of the primary drug while minimizing adverse effects.

CAS 1160572-37-1

Mitoxantrone Impurity 1

Mitoxantrone Impurity 1

Ref: 4Z-M-088007

1,4,5,8-Tetrakis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione

Ref: TR-T403485